BlackRock Investment Management’s ResMed RMD Stock Holding History

BlackRock Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$30.8M	Buy	496,340 +84,043	+20%	+$5.15M	0.04%	443
2016 Q3	$26.7M	Sell	412,297 -1,843	-0.4%	-$123K	0.03%	449
2016 Q2	$26.2M	Buy	414,140 +12,116	+3%	+$714K	0.03%	444
2016 Q1	$23.2M	Sell	402,024 -9,176	-2%	-$519K	0.03%	499
2015 Q4	$22.1M	Sell	411,200 -1,314	-0.3%	-$74.1K	0.03%	518
2015 Q3	$21M	Sell	412,514 -9,809	-2%	-$528K	0.03%	526
2015 Q2	$23.8M	Buy	422,323 +25,319	+6%	+$1.6M	0.03%	511
2015 Q1	$28.5M	Buy	397,004 +4,250	+1%	+$276K	0.04%	430
2014 Q4	$22M	Sell	392,754 -7,936	-2%	-$414K	0.03%	506
2014 Q3	$19.7M	Buy	400,690 +227	+0.1%	+$11.6K	0.03%	532
2014 Q2	$20.3M	Sell	400,463 -5,752	-1%	-$285K	0.03%	541
2014 Q1	$18.2M	Sell	406,215 -2,318	-0.6%	-$104K	0.03%	559
2013 Q4	$19.2M	Sell	408,533 -3,910	-0.9%	-$198K	0.03%	528
2013 Q3	$21.8M	Buy	412,443 +37,542	+10%	+$1.82M	0.04%	452
2013 Q2	$16.9M	Buy	+374,901	New	+$17.8M	0.03%	485

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

BlackRock Investment Management's RMD Position: Q4 2016 in Review

BlackRock Investment Management increased its ResMed (RMD) stake by 20% in Q4 2016, buying an estimated $5.15M and bringing the position to 496,340 shares worth $30.8M. The position accounts for 0.04% of the portfolio, ranked #443.

BlackRock Investment Management first reported a position in RMD in Q2 2013 and has held it in 15 quarters since. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

BlackRock Investment Management held 496,340 shares of ResMed worth $30.8M as of Q4 2016.
BlackRock Investment Management bought 84,043 ResMed shares in Q4 2016, an estimated $5.15M.
ResMed made up 0.04% of BlackRock Investment Management's portfolio in Q4 2016, its #443 holding.
BlackRock Investment Management first reported a position in ResMed in Q2 2013 and has held it in 15 quarters since.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.